Libro

Pseudomonas aeruginosa remains one of the most clinically challenging opportunistic pathogens in modern medicine, driven by its remarkable metabolic versatility, intrinsic resistance mechanisms, and capacity for rapid adaptive evolution. This comprehensive reference provides an integrated, evidence-based synthesis of the organism’s microbiology, pathogenesis, and clinical management, bridging fundamental science with translational and applied perspectives. The volume systematically explores the genetic architecture and regulatory networks that underpin virulence, including quorum sensing systems, secretion pathways, and biofilm-associated persistence. Detailed coverage is given to host–pathogen interactions, highlighting immune evasion strategies and the dynamic transition between acute and chronic infection phenotypes. Special emphasis is placed on biofilm biology and its critical role in antimicrobial tolerance and therapeutic failure. Clinically, the book addresses the full spectrum of P. aeruginosa infections, from healthcare-associated pneumonia and bloodstream infections to chronic pulmonary disease in cystic fibrosis. Diagnostic approaches, antimicrobial susceptibility testing, and current treatment strategies are critically evaluated in the context of escalating multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. Emerging therapeutic directions—including phage therapy, anti-virulence approaches, and novel antimicrobial agents—are also discussed. Designed for clinicians, microbiologists, researchers, and advanced students, this reference offers a structured and authoritative resource aligned with current global priorities in infectious disease research. By integrating molecular insights with clinical application, it provides a rigorous foundation for understanding and addressing one of the most significant bacterial threats in healthcare settings worldwide.